MedPath

Safety and Efficacy of the Application of Photobiomodulation (PBM) on Intensive Care Unit (ICU) Patients with Acute Delirium

Not Applicable
Conditions
Acute delirium
Neurological - Other neurological disorders
Registration Number
ACTRN12623001268639
Lead Sponsor
Mater Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

Patients in the ICU
Aged 18 years or older and
Who have been diagnosed with acute delirium using the CAM-ICU tool.

Exclusion Criteria

(i) Pregnancy
(ii) Intracranial metal implants, e.g., Deep Brain Stimulator
(iii) Uncontrolled psychiatric condition within the last 3 months
(iv) Suspected acute drug or alcohol withdrawal
(v) Structural lesion on neuroimaging which excludes a diagnosis of delirium

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in quantitative electroencephalography (QEEG) to determine cortical electrical activity of brainwaves (beta, alpha, theta and delta).[ Once at: Baseline prior to commencement of intervention.<br>Once more: At end of intervention phase to assess for any changes.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath